CanSino Biologics Inc. (OTCMKTS:CASBF) Short Interest Up 37.0% in November

CanSino Biologics Inc. (OTCMKTS:CASBF) was the target of a significant growth in short interest in November. As of November 30th, there was short interest totalling 14,800 shares, a growth of 37.0% from the November 15th total of 10,800 shares. Based on an average daily trading volume, of 100 shares, the days-to-cover ratio is presently 148.0 days.

CanSino Biologics Price Performance

CanSino Biologics stock remained flat at C$4.35 during midday trading on Friday. The stock has a 50 day moving average of C$3.77 and a 200-day moving average of C$2.93. CanSino Biologics has a 12-month low of C$1.86 and a 12-month high of C$4.35.

About CanSino Biologics

CanSino Biologics Inc develops, manufactures, and commercializes vaccines in the People's Republic of China. The company develops Convidecia and the Ad5-nCoV for Inhalation vaccines to recombinant novel coronavirus disease; Ad5-EBOV, an Ebola virus vaccine; and MCV2 and MCV4 vaccines for the prevention of N.